BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19577448)

  • 1. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N; Tramonti G; Corti A; Chieli E
    Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction potential of herbal medicinal products: a luminescence-based screening platform assessing effects on cytochrome P450 and its use with devil's claw (Harpagophyti radix) preparations.
    Modarai M; Suter A; Kortenkamp A; Heinrich M
    J Pharm Pharmacol; 2011 Mar; 63(3):429-38. PubMed ID: 21749392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N; Turner MW; McDougal OM
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
    Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
    Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N; Heard C
    J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
    Hostanska K; Melzer J; Rostock M; Suter A; Saller R
    J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (Devil's Claw).
    Ouitas NA; Heard C
    Phytother Res; 2010 Mar; 24(3):333-8. PubMed ID: 19610038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
    Inaba K; Murata K; Naruto S; Matsuda H
    J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety.
    Brien S; Lewith GT; McGregor G
    J Altern Complement Med; 2006 Dec; 12(10):981-93. PubMed ID: 17212570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
    Anauate MC; Torres LM; de Mello SB
    Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract.
    Axmann S; Hummel K; Nöbauer K; Razzazi-Fazeli E; Zitterl-Eglseer K
    J Vet Pharmacol Ther; 2019 Jan; 42(1):37-44. PubMed ID: 30242850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fight against Infection and Pain: Devil's Claw (
    Gxaba N; Manganyi MC
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
    [No Abstract]   [Full Text] [Related]  

  • 13. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
    Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
    J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
    Joubert E; Manley M; Gray BR; Schulz H
    J Agric Food Chem; 2005 May; 53(9):3493-502. PubMed ID: 15853393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data.
    Menghini L; Recinella L; Leone S; Chiavaroli A; Cicala C; Brunetti L; Vladimir-Knežević S; Orlando G; Ferrante C
    Phytother Res; 2019 Sep; 33(9):2152-2162. PubMed ID: 31273865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
    Stewart KM; Cole D
    J Ethnopharmacol; 2005 Sep; 100(3):225-36. PubMed ID: 16112533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease.
    Whitehouse LW; Znamirowska M; Paul CJ
    Can Med Assoc J; 1983 Aug; 129(3):249-51. PubMed ID: 6407745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harpagoside: from Kalahari Desert to pharmacy shelf.
    Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
    Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems.
    Georgiev MI; Alipieva K; Orhan IE
    Phytother Res; 2012 Feb; 26(2):313-6. PubMed ID: 21721061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.).
    Wegener T; Lüpke NP
    Phytother Res; 2003 Dec; 17(10):1165-72. PubMed ID: 14669250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.